View:
United States securities and exchange commission logo
February 23, 2024
David M. Urso
President & Chief Executive Officer
MEI Pharma, Inc.
11455 El Camino Real Suite 250
San Diego, California 92130
Re: MEI Pharma, Inc.
Registration
Statement on Form S-3
Filed February 20,
2024
File No. 333-277201
Dear David M. Urso:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Tim
Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Justin W. Chairman,
Esq.